# active_site_0085

[All questions and paired results](../README.md) · [Method](../METHOD.md) · [Source credits](../THIRD_PARTY_NOTICES.md)

**Task:** `active_site`  
**Author expected answer:** **C** — Position 60 (Cysteine sulfenic acid (-SOH) intermediate)

| Reviewer | Expected-answer support | Reasoning / lookup | Validity |
|---|---|---|---|
| GPT-6 Luna | supported | lookup-dependent | valid_review |
| Qwen3.8-Flash-Next-NVFP4 | supported | reasoning-supported | valid_review |

**Paired comparison:** key agree; reasoning differ. Agreement is not proof of correctness. These are separate AI judgments, with no forced consensus or changed key.

## Complete original question

```text
[Protein Sequence]
MAPLQPGDSFPANVVFSYIPPTGSLDLTVCGRPIEYNASEALAKGTSVLVAVPGAFTPTCQEKHVTGFIAKLDQLRQAGVDRVLFIASNDAFVMSAWGKANGIKDESILFLSDSDTAFSSSIGWANAGRTGRYAIVVKDGKVVYAAVDTVRGSTEKSGVDAVLTVLGNQGKL

[Multiple Choices]
A. Position 341 (For beta-ketoacyl synthase activity)
B. Position 959 (Proton acceptor; for dehydratase activity)
C. Position 60 (Cysteine sulfenic acid (-SOH) intermediate)
D. Position 151 (Proton acceptor)
```

<details>
<summary>Original system instructions, verbatim</summary>

```text
You are an excellent scientist. Analyze the provided protein-related task carefully and choose the correct answer from the multiple-choice options.

The current task is about Enzyme Active Site Prediction, which is to identify the key amino acid residues that form the active site of an enzyme. The active site is the specific region on the enzyme where a substrate binds and the chemical reaction is catalyzed. Based on the full protein sequence provided, you must select the option that correctly lists the amino acid residues (by their type and position) that constitute the enzyme's catalytic center.. The inputs provided by the user for this task include:

* Protein Sequence: The amino acid sequence of the protein.
* Multiple Choices: Candidate answers for the protein-related question.

Please think step-by-step about this problem:
1. Analyze the protein sequence carefully.
2. Consider the biological context and function.
3. Evaluate each multiple-choice option.
4. Provide your reasoning process.
5. Finally, give your answer.

Provide your response in the following format:
1. reasoning: [Your detailed reasoning here]
2. answer: Your final answer, which should be "A", "B", "C" or "D".
```

</details>

## GPT-6 Luna

**Saved status:** `valid_review`.

### Expected-answer support: supported

> The exact sequence matches UniProt entry G0S1P8, whose active-site annotation places a cysteine sulfenic-acid intermediate at position 60. The annotation is transferred by similarity from P38013 (ECO:0000250), so it supports the key but is not direct experimental evidence for this sequence.

Citations as saved: [C1](#evidence-c1), [C4](#evidence-c4), [C5](#evidence-c5), [H2](#evidence-h2).

### Reasoning versus lookup: lookup-dependent

**Discriminating biological argument**

> The sequence is 172 residues long, ruling out positions 341 and 959, and position 60 is a cysteine, making option C chemically plausible. But those facts alone do not establish that this cysteine is catalytic; position 151 is also within range, and the sequence input does not identify the enzyme family or provide a structure or homolog annotation.


**Missing item-specific fact**

> The mapping of this protein's catalytic function to Cys60—available from the protein-specific active-site annotation or homolog evidence—is needed to distinguish C from the remaining plausible choice.


**Reason**

> Selecting C requires protein-specific functional annotation or equivalent homology knowledge absent from the model input. Merely recognizing or retrieving the matching database entry would be lookup, not reasoning from the supplied sequence.


### Question ambiguity

**Multiple defensible options, exactly as saved:**

```json
[]
```

> The matched annotation supports C; the fact that the input alone does not establish the catalytic assignment is an answerability limitation, not evidence that another option is correct.


### Important caveats

- The current and archived UniProt records match the supplied sequence, but the annotation evidence is transferred from P38013 rather than independently verified here.
- Reviewer-only accession and annotation evidence were not supplied to the evaluated model.

<details>
<summary>Complete saved parsed visible review</summary>

```json
{
  "answerability_check": {
    "discriminating_biological_argument": "The sequence is 172 residues long, ruling out positions 341 and 959, and position 60 is a cysteine, making option C chemically plausible. But those facts alone do not establish that this cysteine is catalytic; position 151 is also within range, and the sequence input does not identify the enzyme family or provide a structure or homolog annotation.",
    "judgment": "lookup_or_memorization_dependent",
    "missing_item_specific_fact": "The mapping of this protein's catalytic function to Cys60—available from the protein-specific active-site annotation or homolog evidence—is needed to distinguish C from the remaining plausible choice.",
    "reason": "Selecting C requires protein-specific functional annotation or equivalent homology knowledge absent from the model input. Merely recognizing or retrieving the matching database entry would be lookup, not reasoning from the supplied sequence."
  },
  "case_id": "active_site_0085",
  "expected_answer_check": {
    "evidence_ids": [
      "C1",
      "C4",
      "C5",
      "H2"
    ],
    "judgment": "supported",
    "reason": "The exact sequence matches UniProt entry G0S1P8, whose active-site annotation places a cysteine sulfenic-acid intermediate at position 60. The annotation is transferred by similarity from P38013 (ECO:0000250), so it supports the key but is not direct experimental evidence for this sequence."
  },
  "important_caveats": [
    "The current and archived UniProt records match the supplied sequence, but the annotation evidence is transferred from P38013 rather than independently verified here.",
    "Reviewer-only accession and annotation evidence were not supplied to the evaluated model."
  ],
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "The matched annotation supports C; the fact that the input alone does not establish the catalytic assignment is an answerability limitation, not evidence that another option is correct."
  }
}
```

</details>

<details>
<summary>Exact saved visible final text</summary>

```text
{
  "case_id": "active_site_0085",
  "expected_answer_check": {
    "judgment": "supported",
    "reason": "The exact sequence matches UniProt entry G0S1P8, whose active-site annotation places a cysteine sulfenic-acid intermediate at position 60. The annotation is transferred by similarity from P38013 (ECO:0000250), so it supports the key but is not direct experimental evidence for this sequence.",
    "evidence_ids": ["C1", "C4", "C5", "H2"]
  },
  "answerability_check": {
    "judgment": "lookup_or_memorization_dependent",
    "discriminating_biological_argument": "The sequence is 172 residues long, ruling out positions 341 and 959, and position 60 is a cysteine, making option C chemically plausible. But those facts alone do not establish that this cysteine is catalytic; position 151 is also within range, and the sequence input does not identify the enzyme family or provide a structure or homolog annotation.",
    "missing_item_specific_fact": "The mapping of this protein's catalytic function to Cys60—available from the protein-specific active-site annotation or homolog evidence—is needed to distinguish C from the remaining plausible choice.",
    "reason": "Selecting C requires protein-specific functional annotation or equivalent homology knowledge absent from the model input. Merely recognizing or retrieving the matching database entry would be lookup, not reasoning from the supplied sequence."
  },
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "The matched annotation supports C; the fact that the input alone does not establish the catalytic assignment is an answerability limitation, not evidence that another option is correct."
  },
  "important_caveats": [
    "The current and archived UniProt records match the supplied sequence, but the annotation evidence is transferred from P38013 rather than independently verified here.",
    "Reviewer-only accession and annotation evidence were not supplied to the evaluated model."
  ]
}
```

</details>

## Qwen3.8-Flash-Next-NVFP4

**Saved status:** `valid_review`.

### Expected-answer support: supported

> UniProt entry G0S1P8 (sequence SHA256 match, 172 AA) annotates position 60 as 'Cysteine sulfenic acid (-SOH) intermediate' active site (evidence C5, H2). The annotation evidence code is ECO:0000250 (inferred by similarity from P38013), making it a similarity-based annotation rather than direct experimental measurement. However, the protein is annotated as Peroxiredoxin AHP1 (EC 1.11.1.24), and the cysteine sulfenic acid intermediate mechanism is the well-established catalytic mechanism of peroxiredoxins. Position 60 in the supplied sequence is indeed a Cysteine (verified by counting), embedded in a TPTC context consistent with the peroxidatic cysteine motif.

Citations as saved: [C1](#evidence-c1), [C4](#evidence-c4), [C5](#evidence-c5), [H1](#evidence-h1), [H2](#evidence-h2).

### Reasoning versus lookup: reasoning-supported

**Discriminating biological argument**

> Three reasoning steps distinguish the answer: (1) The sequence is only 172 residues, so positions 341 (A) and 959 (B) are physically impossible and can be eliminated by simple counting. (2) The sequence contains hallmark peroxiredoxin features: ~172 AA length, the conserved 'CGRPIEYNASEALAKGTSVLVAVPGAFTPTC' region with a TPTC motif at positions 57–60, and a second Cys at position 30 (resolving cysteine context). (3) The catalytic mechanism of peroxiredoxins universally involves a peroxidatic cysteine forming a sulfenic acid (-SOH) intermediate — this is general enzymology, not protein-specific memorization. Position 60 is a Cys in the TPTC context, matching the peroxidatic Cys. Position 151 is an Arg, which does not fit the peroxiredoxin catalytic mechanism.


**Missing item-specific fact**

> None strictly required. The exact position number (60) can be confirmed by counting Cys residues in the TPTC motif from the supplied sequence. Recognizing the protein as a peroxiredoxin from sequence motifs and applying general peroxiredoxin biochemistry suffices.


**Reason**

> The question is answerable through: (a) trivial length-based elimination of impossible positions, (b) recognition of peroxiredoxin sequence motifs (TPTC, conserved Cys residues, ~170 AA length), and (c) general knowledge that peroxiredoxin catalysis proceeds through a cysteine sulfenic acid intermediate. The choice between C and D is resolved by knowing that the catalytic residue in peroxiredoxins is a cysteine (not an arginine) and that its mechanism involves sulfenic acid formation.


### Question ambiguity

**Multiple defensible options, exactly as saved:**

```json
[]
```

> Choices A and B reference positions far exceeding the 172-residue sequence, making them trivially impossible. Choice D (position 151, Arg, 'proton acceptor') is inconsistent with peroxiredoxin catalytic chemistry. Only C is internally consistent with both the sequence content (Cys at 60 in TPTC motif) and peroxiredoxin mechanism.


### Important caveats

- The UniProt annotation for position 60 is ECO:0000250 (similarity-based inference from P38013, a yeast peroxiredoxin), not direct experimental evidence for this specific protein. However, the peroxiredoxin catalytic mechanism is extensively validated across the family.
- The sequence identity of the protein (peroxiredoxin) is inferable from motifs but not explicitly stated in the question; a model unfamiliar with peroxiredoxin sequence signatures might struggle to choose between C and D without recognizing the fold.
- The reviewer-only evidence was not available to the evaluated model; the reasoning chain described above relies only on the supplied sequence and general biochemistry.

<details>
<summary>Complete saved parsed visible review</summary>

```json
{
  "answerability_check": {
    "discriminating_biological_argument": "Three reasoning steps distinguish the answer: (1) The sequence is only 172 residues, so positions 341 (A) and 959 (B) are physically impossible and can be eliminated by simple counting. (2) The sequence contains hallmark peroxiredoxin features: ~172 AA length, the conserved 'CGRPIEYNASEALAKGTSVLVAVPGAFTPTC' region with a TPTC motif at positions 57–60, and a second Cys at position 30 (resolving cysteine context). (3) The catalytic mechanism of peroxiredoxins universally involves a peroxidatic cysteine forming a sulfenic acid (-SOH) intermediate — this is general enzymology, not protein-specific memorization. Position 60 is a Cys in the TPTC context, matching the peroxidatic Cys. Position 151 is an Arg, which does not fit the peroxiredoxin catalytic mechanism.",
    "judgment": "reasoning_supported",
    "missing_item_specific_fact": "None strictly required. The exact position number (60) can be confirmed by counting Cys residues in the TPTC motif from the supplied sequence. Recognizing the protein as a peroxiredoxin from sequence motifs and applying general peroxiredoxin biochemistry suffices.",
    "reason": "The question is answerable through: (a) trivial length-based elimination of impossible positions, (b) recognition of peroxiredoxin sequence motifs (TPTC, conserved Cys residues, ~170 AA length), and (c) general knowledge that peroxiredoxin catalysis proceeds through a cysteine sulfenic acid intermediate. The choice between C and D is resolved by knowing that the catalytic residue in peroxiredoxins is a cysteine (not an arginine) and that its mechanism involves sulfenic acid formation."
  },
  "case_id": "active_site_0085",
  "expected_answer_check": {
    "evidence_ids": [
      "C1",
      "C4",
      "C5",
      "H1",
      "H2"
    ],
    "judgment": "supported",
    "reason": "UniProt entry G0S1P8 (sequence SHA256 match, 172 AA) annotates position 60 as 'Cysteine sulfenic acid (-SOH) intermediate' active site (evidence C5, H2). The annotation evidence code is ECO:0000250 (inferred by similarity from P38013), making it a similarity-based annotation rather than direct experimental measurement. However, the protein is annotated as Peroxiredoxin AHP1 (EC 1.11.1.24), and the cysteine sulfenic acid intermediate mechanism is the well-established catalytic mechanism of peroxiredoxins. Position 60 in the supplied sequence is indeed a Cysteine (verified by counting), embedded in a TPTC context consistent with the peroxidatic cysteine motif."
  },
  "important_caveats": [
    "The UniProt annotation for position 60 is ECO:0000250 (similarity-based inference from P38013, a yeast peroxiredoxin), not direct experimental evidence for this specific protein. However, the peroxiredoxin catalytic mechanism is extensively validated across the family.",
    "The sequence identity of the protein (peroxiredoxin) is inferable from motifs but not explicitly stated in the question; a model unfamiliar with peroxiredoxin sequence signatures might struggle to choose between C and D without recognizing the fold.",
    "The reviewer-only evidence was not available to the evaluated model; the reasoning chain described above relies only on the supplied sequence and general biochemistry."
  ],
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "Choices A and B reference positions far exceeding the 172-residue sequence, making them trivially impossible. Choice D (position 151, Arg, 'proton acceptor') is inconsistent with peroxiredoxin catalytic chemistry. Only C is internally consistent with both the sequence content (Cys at 60 in TPTC motif) and peroxiredoxin mechanism."
  }
}
```

</details>

<details>
<summary>Exact saved visible final text</summary>

```text


{
  "case_id": "active_site_0085",
  "expected_answer_check": {
    "judgment": "supported",
    "reason": "UniProt entry G0S1P8 (sequence SHA256 match, 172 AA) annotates position 60 as 'Cysteine sulfenic acid (-SOH) intermediate' active site (evidence C5, H2). The annotation evidence code is ECO:0000250 (inferred by similarity from P38013), making it a similarity-based annotation rather than direct experimental measurement. However, the protein is annotated as Peroxiredoxin AHP1 (EC 1.11.1.24), and the cysteine sulfenic acid intermediate mechanism is the well-established catalytic mechanism of peroxiredoxins. Position 60 in the supplied sequence is indeed a Cysteine (verified by counting), embedded in a TPTC context consistent with the peroxidatic cysteine motif.",
    "evidence_ids": ["C1", "C4", "C5", "H1", "H2"]
  },
  "answerability_check": {
    "judgment": "reasoning_supported",
    "discriminating_biological_argument": "Three reasoning steps distinguish the answer: (1) The sequence is only 172 residues, so positions 341 (A) and 959 (B) are physically impossible and can be eliminated by simple counting. (2) The sequence contains hallmark peroxiredoxin features: ~172 AA length, the conserved 'CGRPIEYNASEALAKGTSVLVAVPGAFTPTC' region with a TPTC motif at positions 57–60, and a second Cys at position 30 (resolving cysteine context). (3) The catalytic mechanism of peroxiredoxins universally involves a peroxidatic cysteine forming a sulfenic acid (-SOH) intermediate — this is general enzymology, not protein-specific memorization. Position 60 is a Cys in the TPTC context, matching the peroxidatic Cys. Position 151 is an Arg, which does not fit the peroxiredoxin catalytic mechanism.",
    "missing_item_specific_fact": "None strictly required. The exact position number (60) can be confirmed by counting Cys residues in the TPTC motif from the supplied sequence. Recognizing the protein as a peroxiredoxin from sequence motifs and applying general peroxiredoxin biochemistry suffices.",
    "reason": "The question is answerable through: (a) trivial length-based elimination of impossible positions, (b) recognition of peroxiredoxin sequence motifs (TPTC, conserved Cys residues, ~170 AA length), and (c) general knowledge that peroxiredoxin catalysis proceeds through a cysteine sulfenic acid intermediate. The choice between C and D is resolved by knowing that the catalytic residue in peroxiredoxins is a cysteine (not an arginine) and that its mechanism involves sulfenic acid formation."
  },
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "Choices A and B reference positions far exceeding the 172-residue sequence, making them trivially impossible. Choice D (position 151, Arg, 'proton acceptor') is inconsistent with peroxiredoxin catalytic chemistry. Only C is internally consistent with both the sequence content (Cys at 60 in TPTC motif) and peroxiredoxin mechanism."
  },
  "important_caveats": [
    "The UniProt annotation for position 60 is ECO:0000250 (similarity-based inference from P38013, a yeast peroxiredoxin), not direct experimental evidence for this specific protein. However, the peroxiredoxin catalytic mechanism is extensively validated across the family.",
    "The sequence identity of the protein (peroxiredoxin) is inferable from motifs but not explicitly stated in the question; a model unfamiliar with peroxiredoxin sequence signatures might struggle to choose between C and D without recognizing the fold.",
    "The reviewer-only evidence was not available to the evaluated model; the reasoning chain described above relies only on the supplied sequence and general biochemistry."
  ]
}
```

</details>

## Existing project source checks of Luna’s review

The notes below were prepared for specific claims in the Luna review. They are not independent validation of Qwen’s claims, expert adjudication, or replacement verdicts.

## Project source-check notes

These project-authored, AI-assisted checks assess specific source claims. They are not expert adjudication and do not replace Luna’s saved review or the author key.

No additional case-specific project note was recorded. Citation membership checks do not establish that every scientific argument is correct.

## Reviewer-only source evidence

**Both reviewers received this source evidence separately from the original question. It was not available to the original evaluated model.** Source support and reasoning from the original sequence/choices are distinct assessments.

**Accession:** `G0S1P8` (recovered from dataset image-path metadata, not original question text).  
**Sequence applicability:** historical matched; current matched.  
**Historical cutoff:** 2026-05-07; archived entry version 54. Exact author snapshot unknown.

- All evidence and source identity in this section are reviewer-only and were absent from the evaluated model input.
- UniProt annotations may be experimental, computational, or transferred by similarity; evidence codes and qualifiers are retained.
- The 2026-05-07 cutoff approximates the pinned repository date; the author data-construction date and exact source snapshot remain unknown.
- Selected source fields are excerpts; missing annotation is not evidence of falsehood. Primary papers were not comprehensively retrieved or independently validated.

### Evidence C1

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/G0S1P8.json)  
**Locator:** `/primaryAccession`  
**Scope:** current snapshot; actual author source snapshot unknown.  
**Sequence comparison:** matched.  
**Retrieved:** 2026-11-02T04:28:23.003674+00:00.  

```json
"G0S1P8"
```

Source SHA-256: `ac59354270103a00640e3456b661297eaa89577d53f69bd751d7eb36a829cb5f`.

### Evidence C4

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/G0S1P8.json)  
**Locator:** `/proteinDescription`  
**Scope:** current snapshot; actual author source snapshot unknown.  
**Sequence comparison:** matched.  
**Retrieved:** 2026-11-02T04:28:23.003674+00:00.  

```json
{"alternativeNames":[{"fullName":{"value":"Alkyl hydroperoxide reductase"}}],"recommendedName":{"ecNumbers":[{"evidences":[{"evidenceCode":"ECO:0000250","id":"P38013","source":"UniProtKB"}],"value":"1.11.1.24"}],"fullName":{"evidences":[{"evidenceCode":"ECO:0000305"}],"value":"Peroxiredoxin AHP1"},"shortNames":[{"value":"Prx"}]}}
```

Source SHA-256: `ac59354270103a00640e3456b661297eaa89577d53f69bd751d7eb36a829cb5f`.

### Evidence C5

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/G0S1P8.json)  
**Locator:** `/features/2`  
**Scope:** current snapshot; actual author source snapshot unknown.  
**Sequence comparison:** matched.  
**Retrieved:** 2026-11-02T04:28:23.003674+00:00.  

```json
{"description":"Cysteine sulfenic acid (-SOH) intermediate","evidences":[{"evidenceCode":"ECO:0000250","id":"P38013","source":"UniProtKB"}],"location":{"end":{"modifier":"EXACT","value":60},"start":{"modifier":"EXACT","value":60}},"type":"Active site"}
```

Source SHA-256: `ac59354270103a00640e3456b661297eaa89577d53f69bd751d7eb36a829cb5f`.

### Evidence H1

[UniSave archived UniProt entry](https://rest.uniprot.org/unisave/G0S1P8?format=txt&versions=54)  
**Locator:** `lines 1-15`  
**Scope:** record released no later than 2026-05-07; actual author source snapshot unknown.  
**Sequence comparison:** matched.  
**Entry / sequence version:** 54 / 1.  
**Retrieved:** 2026-11-02T04:28:28.092103+00:00.  

```text
ID   AHP1_CHATD              Reviewed;         172 AA.
AC   G0S1P8;
DT   05-FEB-2025, integrated into UniProtKB/Swiss-Prot.
DT   19-OCT-2011, sequence version 1.
DT   28-JAN-2026, entry version 54.
DE   RecName: Full=Peroxiredoxin AHP1 {ECO:0000305};
DE            Short=Prx;
DE            EC=1.11.1.24 {ECO:0000250|UniProtKB:P38013};
DE   AltName: Full=Alkyl hydroperoxide reductase;
GN   Name=AHP1; ORFNames=CTHT_0014370;
OS   Chaetomium thermophilum (strain DSM 1495 / CBS 144.50 / IMI 039719)
OS   (Thermochaetoides thermophila).
OC   Eukaryota; Fungi; Dikarya; Ascomycota; Pezizomycotina; Sordariomycetes;
OC   Sordariomycetidae; Sordariales; Chaetomiaceae; Thermochaetoides.
OX   NCBI_TaxID=759272;
```

Source SHA-256: `ad6b8e635a2d1310f20d35c06db92e8909dc4cbae80b5fef229cdcd3da0ecf4f`.

### Evidence H2

[UniSave archived UniProt entry](https://rest.uniprot.org/unisave/G0S1P8?format=txt&versions=54)  
**Locator:** `lines 136-138`  
**Scope:** record released no later than 2026-05-07; actual author source snapshot unknown.  
**Sequence comparison:** matched.  
**Entry / sequence version:** 54 / 1.  
**Retrieved:** 2026-11-02T04:28:28.092103+00:00.  

```text
FT   ACT_SITE        60
FT                   /note="Cysteine sulfenic acid (-SOH) intermediate"
FT                   /evidence="ECO:0000250|UniProtKB:P38013"
```

Source SHA-256: `ad6b8e635a2d1310f20d35c06db92e8909dc4cbae80b5fef229cdcd3da0ecf4f`.

---

Original question/key: [pinned source](https://github.com/Rongdingyi/LiveProteinBench/blob/8b9710932511f816651fc1a7e8a1bc85c3c77767/dataset/QA/active_site.json), zero-based source row 85. © 2026 LiveProteinBench contributors; [CC BY 4.0](https://huggingface.co/datasets/LiveProteinBench/LiveProteinBench/blob/8428f64e33d53330f7745376d9c45de2d2c37eaf/LICENSE). UniProt and Gene Ontology credits are retained in [source notices](../THIRD_PARTY_NOTICES.md).
